Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Urinary p-cresol is elevated in small children with severe autism spectrum disorder.

Altieri L, Neri C, Sacco R, Curatolo P, Benvenuto A, Muratori F, Santocchi E, Bravaccio C, Lenti C, Saccani M, Rigardetto R, Gandione M, Urbani A, Persico AM.

Biomarkers. 2011 May;16(3):252-60. doi: 10.3109/1354750X.2010.548010. Epub 2011 Feb 18.

PMID:
21329489
2.

Urinary p-cresol is elevated in young French children with autism spectrum disorder: a replication study.

Gabriele S, Sacco R, Cerullo S, Neri C, Urbani A, Tripi G, Malvy J, Barthelemy C, Bonnet-Brihault F, Persico AM.

Biomarkers. 2014 Sep;19(6):463-70. doi: 10.3109/1354750X.2014.936911. Epub 2014 Jul 10.

PMID:
25010144
3.

Urinary p-cresol in autism spectrum disorder.

Persico AM, Napolioni V.

Neurotoxicol Teratol. 2013 Mar-Apr;36:82-90. doi: 10.1016/j.ntt.2012.09.002. Epub 2012 Sep 10. Review.

PMID:
22975621
4.

Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.

Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R.

Toxicol Appl Pharmacol. 2006 Jul 15;214(2):99-108. Epub 2006 Jun 16.

PMID:
16782144
5.

A biomarker of mercury body-burden correlated with diagnostic domain specific clinical symptoms of autism spectrum disorder.

Kern JK, Geier DA, Adams JB, Geier MR.

Biometals. 2010 Dec;23(6):1043-51. doi: 10.1007/s10534-010-9349-6. Epub 2010 Jun 9.

PMID:
20532957
6.

Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?

Wang L, Angley MT, Gerber JP, Young RL, Abarno DV, McKinnon RA, Sorich MJ.

Biomarkers. 2009 Dec;14(8):596-603. doi: 10.3109/13547500903183962.

PMID:
19697973
7.

Slow intestinal transit contributes to elevate urinary p-cresol level in Italian autistic children.

Gabriele S, Sacco R, Altieri L, Neri C, Urbani A, Bravaccio C, Riccio MP, Iovene MR, Bombace F, De Magistris L, Persico AM.

Autism Res. 2016 Jul;9(7):752-9. doi: 10.1002/aur.1571. Epub 2015 Oct 6.

PMID:
26437875
8.
9.
10.

1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders.

Gabis L, Wei Huang, Azizian A, DeVincent C, Tudorica A, Kesner-Baruch Y, Roche P, Pomeroy J.

J Child Neurol. 2008 Jul;23(7):766-74. doi: 10.1177/0883073808315423. Epub 2008 May 16.

PMID:
18487520
11.

[Urine peptide patterns in children with milder types of autism].

Sponheim E, Myhre AM, Reichelt KL, Aalen OO.

Tidsskr Nor Laegeforen. 2006 May 25;126(11):1475-7. Norwegian.

12.

Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?

Wang L, Angley MT, Sorich MJ, Young RL, McKinnon RA, Gerber JP.

Autism Res. 2010 Oct;3(5):268-72. doi: 10.1002/aur.145.

PMID:
20589913
13.

Structure of the autism symptom phenotype: A proposed multidimensional model.

Georgiades S, Szatmari P, Zwaigenbaum L, Duku E, Bryson S, Roberts W, Goldberg J, Mahoney W.

J Am Acad Child Adolesc Psychiatry. 2007 Feb;46(2):188-96.

PMID:
17242622
14.

Absence of urinary opioid peptides in children with autism.

Cass H, Gringras P, March J, McKendrick I, O'Hare AE, Owen L, Pollin C.

Arch Dis Child. 2008 Sep;93(9):745-50. doi: 10.1136/adc.2006.114389. Epub 2008 Mar 12.

PMID:
18337276
15.

Urinary ortho-cresol concentrations as an indicator of toluene inhalation in glue-sniffers.

Yamazaki K, Tanaka E, Misawa S.

J Forensic Sci Soc. 1992 Jul-Sep;32(3):215-23. Erratum in: J Forensic Sci Soc 1992 Oct-Dec;32(4):381.

PMID:
1492880
16.

Modeling clinical outcome of children with autistic spectrum disorders.

Coplan J, Jawad AF.

Pediatrics. 2005 Jul;116(1):117-22.

PMID:
15995041
17.

Child behavior checklist clinical scales discriminate referred youth with autism spectrum disorder: a preliminary study.

Biederman J, Petty CR, Fried R, Wozniak J, Micco JA, Henin A, Doyle R, Joshi G, Galdo M, Kotarski M, Caruso J, Yorks D, Faraone SV.

J Dev Behav Pediatr. 2010 Jul-Aug;31(6):485-90. doi: 10.1097/DBP.0b013e3181e56ddd.

PMID:
20585266
18.

Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders.

Bull G, Shattock P, Whiteley P, Anderson R, Groundwater PW, Lough JW, Lees G.

Med Sci Monit. 2003 Oct;9(10):CR422-5.

PMID:
14523330
19.

Autism and pervasive developmental disorders.

Volkmar FR, Lord C, Bailey A, Schultz RT, Klin A.

J Child Psychol Psychiatry. 2004 Jan;45(1):135-70. Review.

PMID:
14959806
20.

Pervasive developmental disorders in individuals with cerebral palsy.

Kilincaslan A, Mukaddes NM.

Dev Med Child Neurol. 2009 Apr;51(4):289-94. doi: 10.1111/j.1469-8749.2008.03171.x.

Supplemental Content

Support Center